In our current analysis, we examined and validated 1,250 disruptive players (or 18.3% of life science industry players) from over 6,800 companies in key healthcare markets. These companies are leaders in influencing therapeutic processes across the entire patient pathway and at the same time leaders in the digital transformation of healthcare worldwide. We call them "Healthcare Movers" (or HCM).
Key aspects of our analysis are:
A high relative score shows that successful players make greater use of the most important new business factors than traditional players.
HCM companies understand the importance of future-oriented strategic investments in three key factors, namely the strength of the acquisition of healthcare data, the technological strengthening of the offering at the highest level including crucial emerging ICT competencies, and the expansion of agility in the business models.
The Top 100 HCM cohorts clearly outperform the average HCM peer companies; they design and implement highly integrative business models in the healthcare sector that far exceed the core industry.
The report covers mainly the industrial companies in the healthcare industry from Austria, Canada, Denmark, Finland, France, Norway, Sweden, Switzerland, the United Kingdom and Ireland. Analysis of other key markets is ongoing and will be updated at a later date.
We would like to invite you to a self-assessment of your company and a first dialogue with our experts on the findings of the Healthcare Movers Analysis. Please do not hesitate to contact us at your convenience.
++ ++ Management praise ++ ++ Management recommendation ++ ++
"A new evaluation of the level of #healthcare organizations in terms of #digital #transformation and #agility by Beatus Hofrichter ! Wow! Breadth and depth at its best!"
Healthcare Shapers - Board Member